Partial
Partially Aligned
Patient Risk:
Moderate
Summary
Some general statements align with label themes (LDL reduction; common adverse reactions like myalgia/diarrhea/nausea), but many specific claims about side effects (sleep disturbances, headache, fatigue, peripheral neuropathy), FDA wording, study/citation assertions, and cancer/memory/dementia/type 2 diabetes are not supported by the provided prescribing-information excerpts and/or are not verifiable as stated.
Category Scores
Accurate Statements
Lipitor (atorvastatin) is a statin medication that reduces the production of low-density lipoprotein (LDL) cholesterol.
Section 12.1 mechanism and Section 14.2 hyperlipidemia efficacy (LDL-C reduction). Provided excerpts do not explicitly say “reduces the production of LDL cholesterol,” but they do support cholesterol reduction and LDL-C lowering.
Lipitor (atorvastatin) is associated with common side effects including muscle pain or weakness.
Section 6.1 lists myalgia among the five most common adverse reactions leading to discontinuation; label also discusses serious muscle effects elsewhere (5.1).
Lipitor (atorvastatin) is associated with common side effects including diarrhea.
Section 6.1 lists diarrhea among the five most common adverse reactions.
Lipitor (atorvastatin) is associated with common side effects including nausea or vomiting.
Section 6.1 lists nausea among the five most common adverse reactions leading to discontinuation (label excerpt does not separately list vomiting).
Lipitor (atorvastatin) can cause liver damage.
Section 5.2 describes liver dysfunction with statins and biochemical abnormalities of liver function; adverse reaction discussion includes liver enzyme abnormalities.
Lipitor (atorvastatin) can cause muscle damage.
Section 5.1 includes rhabdomyolysis/myopathy; Section 6.1 references myopathy/rhabdomyolysis as serious adverse reactions discussed elsewhere.
Unsupported Statements
Lipitor (atorvastatin) is associated with common side effects including headache.
Section 6.1 excerpt lists myalgia, diarrhea, nausea, and enzyme increases; headache is not supported by the provided excerpts.
Lipitor (atorvastatin) is associated with common side effects including abdominal pain.
Abdominal pain is not supported by the provided Section 6.1 excerpt.
Lipitor (atorvastatin) is associated with common side effects including fatigue.
Fatigue is not supported by the provided excerpts (including Section 6.1).
Lipitor (atorvastatin) is associated with common side effects including sleep disturbances.
Sleep disturbances are not supported by the provided excerpts.
Some studies have suggested a link between Lipitor (atorvastatin) and memory loss.
No provided label excerpt addresses memory loss.
Some studies have suggested a link between Lipitor (atorvastatin) and cognitive impairment.
No provided label excerpt addresses cognitive impairment.
Some studies have suggested a link between Lipitor (atorvastatin) and dementia.
No provided label excerpt addresses dementia.
A study in the Journal of Clinical Psychopharmacology found patients taking Lipitor were more likely to experience memory loss and cognitive decline compared to placebo.
The provided label excerpts do not cite this study or provide this finding.
Liver damage from Lipitor is said to be particularly associated with high doses or extended periods of use.
The provided excerpts discuss monitoring and contraindications; they do not state liver damage is “particularly associated with high doses or extended periods.”
The FDA states liver damage is a rare but serious side effect of Lipitor (atorvastatin).
No provided label excerpt contains this FDA-phrasing or a “rare but serious side effect” characterization specifically for liver damage.
Some studies have suggested Lipitor (atorvastatin) may increase the risk of developing type 2 diabetes.
No provided label excerpt addresses type 2 diabetes risk.
A study in the Journal of the American Medical Association found patients taking Lipitor were more likely to develop diabetes compared to placebo.
The provided label excerpts do not cite this JAMA study or provide this finding.
Muscle damage from Lipitor is said to be particularly associated with older adults.
The provided excerpts do not state that muscle damage is particularly associated with older adults.
The FDA states muscle damage is a rare but serious side effect of Lipitor (atorvastatin).
No provided label excerpt contains this exact FDA-phrasing.
Lipitor (atorvastatin) can cause nervous system damage.
No provided label excerpt supports “nervous system damage” as an adverse effect.
Lipitor (atorvastatin) can cause peripheral neuropathy.
Peripheral neuropathy is not supported by the provided label excerpts.
The FDA states nervous system damage is a rare but serious side effect of Lipitor (atorvastatin).
No provided label excerpt supports this FDA-phrasing, nor nervous system damage as a stated risk.
Some studies have suggested Lipitor (atorvastatin) may increase the risk of certain types of cancer.
No provided label excerpt addresses cancer risk.
Some studies have suggested Lipitor (atorvastatin) may increase the risk of liver cancer.
No provided label excerpt addresses liver cancer risk.
A study in the Journal of the National Cancer Institute found patients taking Lipitor were more likely to develop liver cancer compared to placebo.
The provided label excerpts do not cite this study or provide this finding.
The article states that Lipitor can cause memory loss and cognitive impairment, particularly in older adults.
No provided label excerpt addresses memory/cognitive effects or older-adult emphasis.
The article states that Lipitor can cause liver damage, particularly when taken in high doses or for extended periods.
The provided label excerpts do not state this dose/duration specificity.
The article states that Lipitor may increase the risk of developing type 2 diabetes.
No provided label excerpt addresses type 2 diabetes risk.
The article states that Lipitor can cause muscle damage, particularly in older adults.
The provided excerpts do not state muscle damage is particularly associated with older adults.
The article states that Lipitor may increase the risk of certain types of cancer, including liver cancer.
No provided label excerpt addresses cancer risk.
Contradictions
Important Omissions
Any mention of contraindications (active liver disease, pregnancy, nursing mothers) and key warnings/precautions such as the need for liver function tests, and management of myopathy/rhabdomyolysis risk with interacting drugs.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Several safety claims appear unsupported by the provided label excerpts (e.g., peripheral neuropathy, nervous system damage, memory/cognitive impairment, cancer, type 2 diabetes, and FDA-specific “rare but serious” phrasing). While some common adverse reactions and major risks (muscle, liver) are consistent with label excerpts, the presence of many unsupported and potentially misleading statements increases risk of inaccurate information.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Partially Aligned
Primary Issue
Numerous claims (study citations, FDA phrasing, specific adverse effects like sleep disturbance/headache/abdominal pain/fatigue/peripheral neuropathy, and risks like memory loss, cancer, and type 2 diabetes) are not supported by the provided prescribing-information excerpts.
Suggested Improvement
Restrict claims to adverse reactions and safety information explicitly supported by the provided label excerpts (e.g., myalgia, diarrhea, nausea; liver enzyme abnormalities; myopathy/rhabdomyolysis; liver function testing and contraindications). Remove or rephrase unsupported study-specific and FDA-phrasing assertions.